Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03162549 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CorEvitas Inflammatory Bowel Disease (IBD) Registry

StatusEnrolling by Invitation
PhaseNot specified
SponsorCorEvitas
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv14
  2. Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    v13
  3. Trial status: Enrolling by Invitation to Recruitingv12 Show 4 more changesShow less
    • Eligibility criteria shortened, about 93 words
    • Study description revised
    • Study site revised
    • Study title revised
  4. 2 versions Re-verified since Mar 7, 2023, no change to tracked fieldsv10-v11
  5. Eligibility criteria expanded, about 6 wordsv9
Show 7 earlier versionsHide 7 earlier versions
  1. 2 versions Re-verified since Apr 16, 2021, no change to tracked fieldsv7-v8
  2. Enrollment target: estimated 1000 to confirmed 2287
    • Eligibility criteria shortened, about 2 words
    • Study description shortened, about 3 words
    v6
  3. Re-verified, no change to tracked fieldsv5
  4. Eligibility criteria expanded, about 141 wordsv4
  5. Re-verified, no change to tracked fieldsv3
  6. Site details revisedv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CorEvitas
24 trials monitored
See all monitored trials
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.
Trial Details
NCT Number NCT03162549
Lead Sponsor CorEvitas
Conditions
(from sponsor)		 Inflammatory Bowel Diseases
Related terms Inflammatory Bowel Diseases
Enrollment 2,287 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov